Hawkins (NASDAQ:HWKN - Get Free Report) was downgraded by Zacks Research from a "strong-buy" rating to a "hold" rating in a research note issued to investors on Monday,Zacks.com reports.
Other analysts have also recently issued research reports about the company. Raymond James Financial began coverage on Hawkins in a report on Thursday, July 24th. They set a "market perform" rating on the stock. BWS Financial increased their price objective on Hawkins from $160.00 to $200.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Finally, Wall Street Zen cut Hawkins from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $162.50.
View Our Latest Analysis on Hawkins
Hawkins Price Performance
Shares of NASDAQ HWKN opened at $171.37 on Monday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.45 and a current ratio of 2.31. Hawkins has a fifty-two week low of $98.30 and a fifty-two week high of $185.50. The stock has a market cap of $3.58 billion, a PE ratio of 42.21, a price-to-earnings-growth ratio of 2.44 and a beta of 0.86. The stock has a fifty day moving average of $169.05 and a 200-day moving average of $140.58.
Hawkins (NASDAQ:HWKN - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The specialty chemicals company reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.33 by $0.07. The business had revenue of $293.27 million for the quarter, compared to analysts' expectations of $278.76 million. Hawkins had a return on equity of 18.35% and a net margin of 8.37%. Equities research analysts anticipate that Hawkins will post 4 earnings per share for the current year.
Institutional Investors Weigh In On Hawkins
A number of hedge funds and other institutional investors have recently modified their holdings of HWKN. Squarepoint Ops LLC bought a new stake in shares of Hawkins in the 4th quarter valued at about $1,754,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Hawkins by 11.2% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 48,378 shares of the specialty chemicals company's stock valued at $5,935,000 after acquiring an additional 4,861 shares during the last quarter. Public Employees Retirement System of Ohio lifted its stake in shares of Hawkins by 13.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 25,556 shares of the specialty chemicals company's stock valued at $3,135,000 after acquiring an additional 3,052 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Hawkins by 12,653.7% in the 1st quarter. GAMMA Investing LLC now owns 56,244 shares of the specialty chemicals company's stock valued at $59,570,000 after acquiring an additional 55,803 shares during the last quarter. Finally, Contravisory Investment Management Inc. bought a new stake in shares of Hawkins in the 1st quarter valued at about $237,000. Institutional investors own 69.71% of the company's stock.
Hawkins Company Profile
(
Get Free Report)
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hawkins, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hawkins wasn't on the list.
While Hawkins currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.